ArticleDermatology online journal2026
Cardiometabolic comorbidities associated with androgenetic alopecia: Findings from a sex-stratified, propensity-matched national cohort.
Article in Dermatology online journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo examine associations between androgenetic alopecia (AGA) and cardiometabolic comorbidities in a large, diverse United States cohort with adjustment for socioeconomic and behavioral factors.
methodsWe conducted a cross-sectional, 1:2 propensity score-matched analysis using data from the All of Us Research Program. Participants with AGA (n = 1015) were matched to controls on age, sex, race, and ethnicity. Thirteen cardiovascular and metabolic conditions were assessed using electronic health records (EHRs). Conditional logistic regression, adjusted for smoking, insurance, income, healthcare access, and marital status, was performed overall and by sex.
resultsAGA was significantly associated with hyperlipidemia in males (adjusted odds ratio [OR], 2.32; 95% confidence interval [CI], 1.56-3.46) and females (adjusted OR, 2.55; 95% CI, 1.98-3.28). In females, AGA was also independently associated with obesity (adjusted OR, 1.48; 95% CI, 1.17-1.86), but this association was not observed in males. Associations with hypertension and valvular heart disease did not persist after adjustment. The cross-sectional design and reliance on structured EHR data limited causal inference.
conclusionAGA is independently associated with hyperlipidemia in both sexes and with obesity in females, suggesting its potential as a clinical marker of cardiometabolic risk.
Indexed as
Identifiers
42246337What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.